The common multiple sclerosis treatment, according to a study out of Duke, may do very little for as many as half of people with the disease. In a mouse model of MS, they identified different disease pathways in those resistant to the treatment, raising questions about the heterogeneity of MS.
In many hospitals there is a consistent effort to monitor how patients are responding to various treatments. This can be done at different increments which can determine in some cases how effective treatments are against pathogens which can affect a patients' health.
Authors of a new study noted that one type of one form of arsenic, trivalent DMA, inhibits insulin-stimulated glucose uptake in cultured fat cells. They considered arsenic exposure a risk factor for type 1 diabetes.
Despite featuring a survey that produced interesting insight into how MS patients respond to their condition through dietary behaviors, researchers considered much of the existing research on the subject inefficient and thus had difficulty creating a program to educate patients.
There is no shortage of caregivers facing the challenge of helping their loved ones on a daily basis for any number of reasons. Getting them help can be done through telemedicine in an effort to reach as many people as possible in an efficient method.